151 related articles for article (PubMed ID: 38678278)
1. Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.
Kirabira J; Kayondo M; Bawakanya SM; Nsubuga EJ; Yarine F; Namuli A; Namugumya R; Natulinda CH; Atwine R; Birungi A; Lugobe HM; Tibaijuka L; Kisombo D; Jjuuko M; Agaba DC; Saturday P; Atupele SM; Tumusiime M; Migisha R; Kajabwangu R
BMC Womens Health; 2024 Apr; 24(1):266. PubMed ID: 38678278
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and correlates of cervical squamous intraepithelial lesions among HIV-infected and uninfected women in Central Kenya.
Njagi SK; Ngure K; Mwaniki L; Kiptoo M; Mugo NR
Pan Afr Med J; 2021; 39():44. PubMed ID: 34422167
[TBL] [Abstract][Full Text] [Related]
3. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
4. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
Nakigozi H; Ndejjo R; Bazeyo W; Nabaggala A; Achola C; Iga M; Kalyesubula S; Kanamwangi B; Mutungi G; Batte C; Mukunya D; Sserwanga L; Gemageine G; Oyoo CA; Nabadda S
BMC Cancer; 2024 Feb; 24(1):243. PubMed ID: 38383366
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results.
Harris TG; Burk RD; Palefsky JM; Massad LS; Bang JY; Anastos K; Minkoff H; Hall CB; Bacon MC; Levine AM; Watts DH; Silverberg MJ; Xue X; Melnick SL; Strickler HD
JAMA; 2005 Mar; 293(12):1471-6. PubMed ID: 15784870
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer awareness and presence of abnormal cytology among HIV-infected women on antiretroviral therapy in rural Andhra Pradesh, India.
Shin SS; Carpenter CL; Ekstrand ML; Wang Q; Grover S; Zetola NM; Yadav K; Sinha S; Nyamathi AM
Int J STD AIDS; 2019 May; 30(6):586-595. PubMed ID: 30813859
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
[TBL] [Abstract][Full Text] [Related]
9. Performance of Cervical Cancer Screening Techniques in HIV-Infected Women in Uganda.
Bansil P; Lim J; Byamugisha J; Kumakech E; Nakisige C; Jeronimo JA
J Low Genit Tract Dis; 2015 Jul; 19(3):215-9. PubMed ID: 25551591
[TBL] [Abstract][Full Text] [Related]
10. Histopathological profile of cervical punch biopsies and risk factors associated with high-grade cervical precancerous lesions and cancer in northwest Ethiopia.
Derbie A; Amare B; Misgan E; Nibret E; Maier M; Woldeamanuel Y; Abebe T
PLoS One; 2022; 17(9):e0274466. PubMed ID: 36094938
[TBL] [Abstract][Full Text] [Related]
11. The magnitude and predictors of cervical squamous intraepithelial lesions among women in Enugu, Nigeria: a cross-sectional study of women in a low-resource setting.
Omeke CA; Enebe JT; Ugwu AI; Onyishi NT; Omeke MC; Enebe NO; Izuka EO; Aniwada EC
Pan Afr Med J; 2022; 41():130. PubMed ID: 35480408
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus infection in HIV-1 infected women in Catalonia (Spain): implications for prevention of cervical cancer.
Stuardo V; Agustí C; Godinez JM; Montoliu A; Torné A; Tarrats A; Alcalde C; Martín D; Fernández-Montoli E; Vanrell C; Solé J; Canet Y; Marqueta JM; Mohamed J; Cuenca I; Lonca M; Sirera G; Ferrer E; Domingo P; Lloveras B; Miro JM; De Sanjosé S; Casabona J
PLoS One; 2012; 7(10):e47755. PubMed ID: 23118894
[TBL] [Abstract][Full Text] [Related]
13. Cervical precancerous and cancerous lesions screening using Pap smear test at Provincial Referral Hospital of Bukavu, Eastern DR Congo: profile and recommendations to stakeholders.
Mayeri DG; Kahasha PM; Kibalama IB; Mongane J; Louguè M; Birindwa EK; Mwimangire SC; Kikuru CK; Materanya JM; Bisimwa YK; Kasago B; Mukengeshai LM
Pan Afr Med J; 2024; 47():57. PubMed ID: 38646136
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014-2016.
Ouh YT; Min KJ; Cho HW; Ki M; Oh JK; Shin SY; Hong JH; Lee JK
J Gynecol Oncol; 2018 Jan; 29(1):e14. PubMed ID: 29185272
[TBL] [Abstract][Full Text] [Related]
15. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
Jain BB; Adhikary T; Sadhukhan PC; Nandi A
J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
[TBL] [Abstract][Full Text] [Related]
16. Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group.
Rezza G; Giuliani M; Branca M; Benedetto A; Migliore G; Garbuglia AR; D'Ubaldo C; Pezzotti P; Cappiello G; Pomponi Formiconi D; Suligoi B; Schiesari A; Ippolito G; Giacomini G
Eur J Epidemiol; 1997 Dec; 13(8):937-43. PubMed ID: 9476825
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital.
Bakari F; Abdul MA; Ahmed SA
Ann Afr Med; 2017; 16(2):74-80. PubMed ID: 28469121
[TBL] [Abstract][Full Text] [Related]
18. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
[TBL] [Abstract][Full Text] [Related]
19. HPV infection and intraepithelial lesions: comparison between HIV positive and negative women.
Roccio M; Dal Bello B; Gardella B; Carrara M; Gulminetti R; Mariani B; Spinillo A
Curr HIV Res; 2012 Oct; 10(7):614-9. PubMed ID: 22934657
[TBL] [Abstract][Full Text] [Related]
20. [Feasibility of cervical smear in HIV-positive women living in Chad].
Mortier E; Doudéadoum N; Némian F; Gaulier A; Kemian M
Bull Soc Pathol Exot; 2016 Aug; 109(3):180-4. PubMed ID: 27299910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
